matexcel 产品代理

产品分类 > 科研试剂 > matexcel 产品代理

matexcel 产品代理

Microbix生产高质量病毒和细菌制剂的业务是该领域近三十年经验的结果,包括菌株选择、可靠和高效的大规模生物培养、纯化和灭活方法。由于Microbix的专业知识,其产品得到了广泛和长期的客户认可,需求持续增长。Microbix目前的生物制剂目录涵盖了一系列与母亲、儿童、儿童、呼吸道、性传播和虫媒疾病有关的病原体。

该公司还运用其生物专业知识开发其他创新和专有技术和产品。其开发项目管道目前包括Kinlytic®尿激酶,一种用于治疗血栓的生物溶栓药物。
价格: 0.00

Childhood Disease Antigens

Dengue Antigens

Gastrointestinal and Other Antigens

STI Antigens

ToRCH Antigens

COVID-19 Products

PROCEEDx™ (RUO)

ONBOARDx™ Kits (RUO)

PTDx™ Proficiency Testing

REDx™ Controls



Microbix Biosystems Inc. develops and commercializes proprietary biological and technological solutions for human health and wellbeing. We manufacture a wide range of critical biological materials for the global diagnostics industry, notably antigens used in immunoassays and Quality Assessment and Proficiency (QAPs™) testing products.

 

Microbix’s business of producing high quality viral and bacterial preparations are the result of nearly three decades of experience in the field, including strain selection, reliable and efficient organism culture at scale, purification and methods of inactivation. As a result of Microbix’s expertise, its products have received widespread and longstanding customer acceptance, with continuing growth in demand. Microbix’s current catalogue of biological preparations covers a range of pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually-transmitted and insect-borne diseases.

 

The company also applies its biological expertise to develop other innovative and proprietary technologies and products. Its development project pipeline currently includes Kinlytic® Urokinase, a biologic thrombolytic drug used to treat blood clots.